...
avdl-img

Avadel Pharmaceuticals PLC, Common Stock

AVDL

NMQ

$10.39

-$0.22

(-2.07%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.27B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.07M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.63
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.41 L
$19.09 H
$10.39

About Avadel Pharmaceuticals PLC, Common Stock

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameAVDLSectorS&P500
1-Week Return3.9%-2.27%-0.57%
1-Month Return-13.56%-3.96%1.21%
3-Month Return-24.16%-9.7%7.57%
6-Month Return-34.61%-3.37%11.45%
1-Year Return-27.49%3.71%28.48%
3-Year Return34.41%3.8%29.52%
5-Year Return44.31%39.78%90.66%
10-Year Return-35.9%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue59.22M22.33M-1.50M27.96M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":37.72,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":2.53,"profit":true},{"date":"2023-12-31","value":47.22,"profit":true}]
Cost of Revenue12.13M5.74M815.00K1.49M846.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":47.36,"profit":true},{"date":"2021-12-31","value":6.72,"profit":true},{"date":"2022-12-31","value":12.31,"profit":true},{"date":"2023-12-31","value":6.98,"profit":true}]
Gross Profit47.09M16.59M(815.00K)(1.49M)27.12M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":35.23,"profit":true},{"date":"2021-12-31","value":-1.73,"profit":false},{"date":"2022-12-31","value":-3.17,"profit":false},{"date":"2023-12-31","value":57.59,"profit":true}]
Gross Margin79.52%74.29%(Infinity%)(99.80%)96.97%[{"date":"2019-12-31","value":82,"profit":true},{"date":"2020-12-31","value":76.61,"profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":-102.91,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses63.92M53.25M85.60M95.22M164.97M[{"date":"2019-12-31","value":38.74,"profit":true},{"date":"2020-12-31","value":32.28,"profit":true},{"date":"2021-12-31","value":51.89,"profit":true},{"date":"2022-12-31","value":57.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(16.83M)(36.66M)(85.55M)(98.56M)(137.85M)[{"date":"2019-12-31","value":-1682600000,"profit":false},{"date":"2020-12-31","value":-3666100000,"profit":false},{"date":"2021-12-31","value":-8554600000,"profit":false},{"date":"2022-12-31","value":-9856100000,"profit":false},{"date":"2023-12-31","value":-13784900000,"profit":false}]
Total Non-Operating Income/Expense(34.24M)(23.89M)(17.54M)(25.22M)(32.81M)[{"date":"2019-12-31","value":-3423900000,"profit":false},{"date":"2020-12-31","value":-2389100000,"profit":false},{"date":"2021-12-31","value":-1754100000,"profit":false},{"date":"2022-12-31","value":-2522000000,"profit":false},{"date":"2023-12-31","value":-3281400000,"profit":false}]
Pre-Tax Income(38.58M)(5.08M)(93.14M)(111.44M)(160.78M)[{"date":"2019-12-31","value":-3858200000,"profit":false},{"date":"2020-12-31","value":-508200000,"profit":false},{"date":"2021-12-31","value":-9314500000,"profit":false},{"date":"2022-12-31","value":-11143900000,"profit":false},{"date":"2023-12-31","value":-16077700000,"profit":false}]
Income Taxes(5.36M)(12.11M)(15.82M)26.02M(501.00K)[{"date":"2019-12-31","value":-20.58,"profit":false},{"date":"2020-12-31","value":-46.53,"profit":false},{"date":"2021-12-31","value":-60.77,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.93,"profit":false}]
Income After Taxes(33.23M)7.03M(77.33M)(137.46M)(160.28M)[{"date":"2019-12-31","value":-472.77,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false}]
Income From Continuous Operations(33.23M)7.03M(77.33M)(137.46M)(160.28M)[{"date":"2019-12-31","value":-472.77,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(33.23M)7.03M(77.33M)(137.46M)(160.28M)[{"date":"2019-12-31","value":-472.77,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1100.3,"profit":false},{"date":"2022-12-31","value":-1955.95,"profit":false},{"date":"2023-12-31","value":-2280.54,"profit":false}]
EPS (Diluted)(0.89)(0.56)(1.32)(2.25)(2.01)[{"date":"2019-12-31","value":-89,"profit":false},{"date":"2020-12-31","value":-56,"profit":false},{"date":"2021-12-31","value":-132,"profit":false},{"date":"2022-12-31","value":-225,"profit":false},{"date":"2023-12-31","value":-201,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AVDL
Cash Ratio 1.54
Current Ratio 2.97
Quick Ratio 2.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AVDL
ROA (LTM) -34.45%
ROE (LTM) -99.52%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AVDL
Debt Ratio Lower is generally better. Negative is bad. 0.53
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.47

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AVDL
Trailing PE NM
Forward PE 15.50
P/S (TTM) 7.25
P/B 13.41
Price/FCF NM
EV/R 6.78
EV/Ebitda NM
PEG 0.07

FAQs

What is Avadel Pharmaceuticals PLC share price today?

Avadel Pharmaceuticals PLC (AVDL) share price today is $10.39

Can Indians buy Avadel Pharmaceuticals PLC shares?

Yes, Indians can buy shares of Avadel Pharmaceuticals PLC (AVDL) on Vested. To buy Avadel Pharmaceuticals PLC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AVDL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Avadel Pharmaceuticals PLC be purchased?

Yes, you can purchase fractional shares of Avadel Pharmaceuticals PLC (AVDL) via the Vested app. You can start investing in Avadel Pharmaceuticals PLC (AVDL) with a minimum investment of $1.

How to invest in Avadel Pharmaceuticals PLC shares from India?

You can invest in shares of Avadel Pharmaceuticals PLC (AVDL) via Vested in three simple steps:

  • Click on Sign Up or Invest in AVDL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Avadel Pharmaceuticals PLC shares
What is Avadel Pharmaceuticals PLC 52-week high and low stock price?

The 52-week high price of Avadel Pharmaceuticals PLC (AVDL) is $19.09. The 52-week low price of Avadel Pharmaceuticals PLC (AVDL) is $9.41.

What is Avadel Pharmaceuticals PLC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Avadel Pharmaceuticals PLC (AVDL) is

What is Avadel Pharmaceuticals PLC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Avadel Pharmaceuticals PLC (AVDL) is 13.41

What is Avadel Pharmaceuticals PLC dividend yield?

The dividend yield of Avadel Pharmaceuticals PLC (AVDL) is 0.00%

What is the Market Cap of Avadel Pharmaceuticals PLC?

The market capitalization of Avadel Pharmaceuticals PLC (AVDL) is $1.27B

What is Avadel Pharmaceuticals PLC’s stock symbol?

The stock symbol (or ticker) of Avadel Pharmaceuticals PLC is AVDL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top